Canertinib | Covalent Inhibitor of EGFR, ERBB2
RATINGS:
Cellular Use: (0 reviews)

In Model Organisms: (0 reviews)
Selectivity
Control Compounds

Probe Summary

Targets Biochemical/Biophysical Potency Cellular Potency
EGFR
  • IC 50:1.5 nM EGFR
  • IC 50:7.4 nM
ERBB2
    • IC 50:9.0 nM
    Covalent Inhibitor
    up to 1 uM

    Selectivity

    Potency
    Cellular
    In Vitro

    EGFR

    Mode of Action: Covalent Inhibitor

    Structure-Activity-Relationship data available? Yes

    DOI Reference: 10.1021/jm990482t

    ERBB2

    Mode of Action: Covalent Inhibitor

    Structure-Activity-Relationship data available? No

    DOI Reference: 10.1021/jm990482t

    In Vivo Validations

    Mouse
    Dose: 20-80 mg/kg
    Route of delivery: Oral

    DOI Reference: 10.1021/jm990482t

    Orthogonal Probes def

    AFATINIB
    LAPATINIB
    SJF1528

    Chemical Information

    Molecular Formula C24H25ClFN5O3
    SMILEs C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1
    InChI InChI=1S/C24H25ClFN5O3/c1-2-23(32)30-21-13-17-20(14-22(21)34-9-3-6-31-7-10-33-11-8-31)27-15-28-24(17)29-16-4-5-19(26)18(25)12-16/h2,4-5,12-15H,1,3,6-11H2,(H,30,32)(H,27,28,29)
    Molecular weight 485.16 Da
    AlogP 0.0
    HBond acceptors 8
    HBond donors 2
    Atoms 59

    References

    Publications

    Cross References

    canSARChEMBLBindingDB

    Vendors

    Note: This is not an exhaustive list and does not indicate endorsement by the portal.

    Expert Reviews


    No SERP comments found for Canertinib

    Probe Canertinib is in the process of SERP review.

    Please continue to check back for new reviews and commentary.